In the present study, we analyzed the characteristics of SIL-TAL1+ T-ALL retrospectively in 15 Chinese patients presented to our department, and made a comparison with the other 47 SIL-TAL1− T-ALL patients administered during the same period. The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.